One of the four sgRNAs is associated with a single nucleotide variant in BRCA2 (c.-796C>T), which has been previously reported in patients with familiar breast and ovarian cancer, yet were classified as VUS in ClinVar (Additional file 7: Table S6). This evidence concerns the gene BRCA2 and ovarian cancer.